Newgenivf Group Limited income statement NIVF
In fiscal 2025, which ended Dec 31, 2025, Newgenivf Group Limited reported revenue of $23.7 million, up 6278.9% from the year before. Net income was $9.9 million, a profit margin of 41.7%. The operating loss came to $10.7 million, an operating margin of -45.2%. Diluted earnings per share were $3.04.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
|---|---|---|---|
| Revenue |
24
+6278.9%
|
0
-92.8%
|
5
|
| Cost of revenue |
4
+4.6%
|
4
+4.4%
|
3
|
| Gross profit |
1
-47.7%
|
2
+8.6%
|
2
|
| Selling, general and administrative |
12
+291.1%
|
3
+82.2%
|
2
|
| Operating expenses |
12
+291.1%
|
3
+82.2%
|
2
|
| Operating income |
-11
-824.3%
|
-1
-2847.3%
|
0
|
| Interest income |
0
-67.6%
|
0
+1242.3%
|
0
|
| Other income (expense) |
20
+10143.6%
|
0
+201.8%
|
0
|
| Pretax income |
10
+1112.6%
|
-1
-986.2%
|
0
|
| Income tax |
—
|
-0
-333.8%
|
—
|
| Net income |
10
+1983.1%
|
-1
-503.0%
|
0
|
| Basic EPS |
214.73
+104.9%
|
-4,408.76
-133.9%
|
13,019.30
|
| Diluted EPS |
3.04
+100.1%
|
-4,408.76
-133.9%
|
13,019.30
|
| Weighted average shares, basic |
0
+38563.0%
|
0
+1090.0%
|
0
|
| Weighted average shares, diluted |
3
+2731009.2%
|
0
+1090.0%
|
0
|
| Other measures | |||
| Depreciation and amortization |
0
+864.6%
|
0
-37.4%
|
0
|
| EBITDA |
-11
-823.6%
|
-1
-1654.2%
|
0
|
| Interest coverage |
-14.02x
|
—
|
—
|
| Margins | |||
| Gross margin |
4.03%
|
491.54%
|
32.74%
|
| Operating margin |
-45.24%
|
-312.24%
|
0.82%
|
| Pretax margin |
41.03%
|
-258.51%
|
2.11%
|
| Profit margin |
41.67%
|
-141.16%
|
2.53%
|
| EBITDA margin |
-44.45%
|
-306.99%
|
1.43%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- NIVF (Nasdaq), NIVFW (Nasdaq)
- Incorporated in
- Virgin Islands, British
- Headquarters
- Bangkok, Thailand
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1981662
- Former names
- ASPAC I Mini Acquisition Corp. (until Mar 1, 2024)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
All 15 Services-Misc Health & Allied Services, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.